Industry News
Fewer HPV vaccine doses still protect against genital warts in girls
Feb 12, 2014
Although the main purpose of the human papillomavirus vaccine is to protect girls from cervical cancer, genital warts caused by certain types of the virus is also prevented by the vaccine. Now, researchers have found that fewer doses of the vaccine still results in risk reduction of genital warts. Read More
Fewer HPV vaccine doses still protect against genital warts in girls
Feb 12, 2014
Although the main purpose of the human papillomavirus vaccine is to protect girls from cervical cancer, genital warts caused by certain types of the virus is also prevented by the vaccine. Now, researchers have found that fewer doses of the vaccine still results in risk reduction of genital warts. Read More
EU rules stop children with cancer benefiting from new drugs
Feb 12, 2014
Leading cancer experts are calling for a change in the European Union regulations on children's cancer drug trials. They argue that the current system denies children new, potentially life-saving drugs.The UK's Institute of Cancer Research (ICR) says if the rules were changed, children would have access to drugs that are currently only being tested in adults. Read More
Researchers bring scientific knowledge and health prevention habits closer to citizens
Feb 12, 2014
As part of a civic science initiative, a group of researchers form the National Institute of Respiratory Diseases (INER) in collaboration with the Mexican Autonomous Technological Institute (ITAM), the National Institute of Carcinology (INCan) and the Philosophical Research Institute at the National Autonomous Mexican University (UNAM); with the support of the Science and Technology National... Read More
A new postal code for cancer
Feb 12, 2014
Scientists have discovered that a polymer can provide a key to get into tumors: Prof. Read More
Better RNA interference, inspired by nature
Feb 12, 2014
Inspired by tiny particles that carry cholesterol through the body, MIT chemical engineers have designed nanoparticles that can deliver snippets of genetic material that turn off disease-causing genes.This approach, known as RNA interference (RNAi), holds great promise for treating cancer and other diseases. Read More
Alcohol-breakdown molecule may play a role in breast cancer development
Feb 12, 2014
New research looking at the biological process involved in breast cancer development has strengthened the argument for a potential link between alcohol consumption and the disease.Alcohol-breakdown molecule may play a role in breast cancer development. Read More
Researchers bring scientific knowledge and health prevention habits closer to citizens
Feb 12, 2014
As part of a civic science initiative, a group of researchers form the National Institute of Respiratory Diseases (INER) in collaboration with the Mexican Autonomous Technological Institute (ITAM), the National Institute of Carcinology (INCan) and the Philosophical Research Institute at the National Autonomous Mexican University (UNAM); with the support of the Science and Technology National... Read More
How blood cancer's growth fueled in acute myelogenous leukemia
Feb 12, 2014
Reinforcing the need to look beyond genomic alterations to understand the complexity of cancer, researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center report that a normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme found in acute myelogenous leukemia (AML), to promote progression of the disease. Read More
Acidic tumour pH inhibits chloroquine drug effect
Feb 12, 2014
Low pH in tumours counteracts the desired effect of the drug chloroquine, according to a new study from Karolinska Institutet. The results, which are published in the scientific journal Autophagy, might explain possible lack of efficacy of chloroquine in clinical studies.Chloroquine, a widely used antimalaria drug, is currently under investigation in clinical trials on cancer patients. Read More
Previous Page Next Page